MNTA’s 2Q11 cash operating expenses* of $16.6M fell right in the middle of the $15-18M quarterly range that MNTA had previously guided to (#msg-65391960). Some iHub posters had expected MNTA’s operating costs to rise sharply, but this hasn’t happened so far.
*Net of R&D revenue, which is a dollar-for-dollar reimbursement by NVS for MNTA’s R&D pursuant to the NVS-MNTA collaborations.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.